Chugai Pharmaceutical Co., Ltd. (CHGCF)
OTCMKTS · Delayed Price · Currency is USD
45.23
-2.55 (-5.35%)
At close: Sep 12, 2025
Chugai Pharmaceutical Market Cap
Chugai Pharmaceutical has a market cap or net worth of $74.58 billion as of September 12, 2025. Its market cap has decreased by -4.66% in one year.
Market Cap
74.58B
Enterprise Value
67.63B
Revenue
8.29B
Ranking
n/a
PE Ratio
27.21
Stock Price
$45.23
Market Cap Chart
Since January 6, 1992, Chugai Pharmaceutical's market cap has increased from 2.50B to 74.58B, an increase of 2,882.13%. That is a compound annual growth rate of 10.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 74.58B | 1.77% |
| Dec 30, 2024 | 73.28B | 17.53% |
| Dec 29, 2023 | 62.35B | 48.41% |
| Dec 30, 2022 | 42.01B | -21.23% |
| Dec 30, 2021 | 53.34B | -39.09% |
| Dec 30, 2020 | 87.57B | 72.72% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 781.22M |
| Elite Pharmaceuticals | 736.80M |
| Tian'an Technology Group | 732.84M |
| Glass House Brands | 585.86M |
| CytoDyn | 397.50M |
| Northwest Biotherapeutics | 380.94M |
| American Oncology Network | 346.29M |